Seeking Alpha·1d ago
AirSculpt Technologies, Inc. (AIRS) Q3 2026 Earnings Call TranscriptAirSculpt Technologies, Inc. (AIRS) Q3 2026 Earnings Call Transcript
AirSculpt Technologies faces a challenging fundamental outlook characterized by sustained revenue contraction and an inability to achieve consistent operating leverage, as evidenced by a recent negative operating margin of -3.18%.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 6, 2026 | -$0.10-233.3% vs -$0.03 | — vs $34M |
Q3 2026 Aug 10, 2026 | $0.01-33.3% vs $0.01 | $43M-2.8% vs $44M |
Q2 2026 May 8, 2026 | -$0.03-50.0% vs -$0.02 | $39M+0.5% vs $39M |
Q2 2026 Apr 2, 2026 | $0.02+180.0% vs -$0.03 | $33M-3.1% vs $34M |
AirSculpt Technologies, Inc. (AIRS) Q3 2026 Earnings Call Transcript
AirSculpt Technologies NASDAQ: AIRS lowered its full-year revenue and profit outlook after third-quarter sales fell 8.7%, as fewer potential patients reached its website and several centers experienced operational problems.
TAMPA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2026.
I rate AirSculpt Technologies a Speculative Buy with a $2.50 target, reflecting a 45% upside from current levels. AIRS's core procedure economics remain attractive, but profitability is pressured by elevated customer acquisition costs and underutilized infrastructure. The investment thesis hinges on AIRS improving marketing efficiency, increasing procedure volume, and securing refinancing without significant shareholder dilution.
Benchmark AIRS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for AirSculpt Technologies, Inc. (AIRS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.53 | $37.66M | -4.12 | -15.82% | -6.36% | -9.43% | — | |
| $15.71 | $102.23M | -5.60 | -10.02% | -6.33% | -32.11% | — | |
| $13.33 | $766.22M | 10.21 | -6.16% | 20.69% | 11.8% | — | |
| $0.00 | $589 | -0.00 | -8.54% | -21.13% | -360.33% | — | |
| $67.02 | $1.97B | -53.03 | 27.14% | -14.56% | -203.65% | — | |
| $101.80 | $130.7B | 25.01 | 8.43% | 13.93% | 10.51% | 2.78% |
AirSculpt Technologies, Inc. (AIRS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
AirSculpt Technologies, Inc. (AIRS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 12, 2026·SEC
Aug 10, 2026·SEC
May 14, 2026·SEC
Get notified when AIRS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AirSculpt Technologies, Inc. (AIRS) stock FAQ — growth, dividends, profitability & financials explained
AirSculpt Technologies, Inc. (AIRS) reported $147.7M in revenue over the trailing twelve months. Revenue was $151.8M in fiscal year 2025. That is 268% more than the $41.2M of fiscal year 2019.
AirSculpt Technologies, Inc. (AIRS) revenue fell by 6.3% over the trailing twelve months, compared with the twelve months before.
No. AirSculpt Technologies, Inc. (AIRS) reported a net loss of $9.4M over the trailing twelve months.
AirSculpt Technologies, Inc. (AIRS) had a return on equity (ROE) of -9.4% over the trailing twelve months. A negative ROE means the company lost money over the period.
AirSculpt Technologies, Inc. (AIRS) had negative free cash flow of $2.5M over the trailing twelve months.
